Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens

Aim In this study, we compared the outcome of cataract extraction in patients with juvenile idiopathic arthritis (JIA)-associated uveitis treated with adalimumab (ADA) compared to patients treated with infliximab (IFX). Patients and methods The study included 22 eyes of 22 children with JIA-a...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariam R Fadel, Elzanaty Hassan, T Radwa, Sara M Esmat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-10-01
Series:Delta Journal of Ophthalmology
Subjects:
Online Access:https://journals.lww.com/djop/fulltext/2024/25040/outcome_of_cataract_surgery_in_juvenile_idiopathic.3.aspx
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850134926809104384
author Mariam R Fadel
Elzanaty Hassan
T Radwa
Sara M Esmat
author_facet Mariam R Fadel
Elzanaty Hassan
T Radwa
Sara M Esmat
author_sort Mariam R Fadel
collection DOAJ
description Aim In this study, we compared the outcome of cataract extraction in patients with juvenile idiopathic arthritis (JIA)-associated uveitis treated with adalimumab (ADA) compared to patients treated with infliximab (IFX). Patients and methods The study included 22 eyes of 22 children with JIA-associated chronic anterior uveitis. The ADA group included 16 patients while the IFX group included six patients. All patients underwent irrigation/aspiration without intraocular lens implantation. The data were collected retrospectively before and 6 months after surgery including best corrected visual acuity (BCVA), intraocular pressure, slit lamp biomicroscopy, and fundus examination. All eyes included in the study had completely inactive intraocular inflammation for 3 months before surgery. The change in BCVA was the main outcome measure. Results The two groups were age and sex matched. In the ADA group, there was a statistically significant improvement in the mean LogMAR BCVA from 1.063±0.33 preoperatively to 0.538±0.54 postoperatively (P=0.0085), while in the IFX group the mean BCVA improved from 1.183±0.475 preoperatively to 0.683±0.594 postoperatively, with no statistically significant difference (P=0.068). The difference in the postoperative BCVA between the two groups was not statistically significant (P=0.68). A larger percentage of patients in the IFX group developed postoperative inflammation (33.3 vs. 25%). Conclusion The visual acuity improved after cataract extraction in patients with JIA-associated uveitis treated with ADA or IFX, but the improvement was more significant in the patients treated with ADA.
format Article
id doaj-art-1da47b67704f49e485c7b5cdd69f5e2b
institution OA Journals
issn 2090-4835
language English
publishDate 2024-10-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Delta Journal of Ophthalmology
spelling doaj-art-1da47b67704f49e485c7b5cdd69f5e2b2025-08-20T02:31:36ZengWolters Kluwer Medknow PublicationsDelta Journal of Ophthalmology2090-48352024-10-0125420520910.4103/djo.djo_30_24Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimensMariam R FadelElzanaty Hassan T Radwa Sara M EsmatAim In this study, we compared the outcome of cataract extraction in patients with juvenile idiopathic arthritis (JIA)-associated uveitis treated with adalimumab (ADA) compared to patients treated with infliximab (IFX). Patients and methods The study included 22 eyes of 22 children with JIA-associated chronic anterior uveitis. The ADA group included 16 patients while the IFX group included six patients. All patients underwent irrigation/aspiration without intraocular lens implantation. The data were collected retrospectively before and 6 months after surgery including best corrected visual acuity (BCVA), intraocular pressure, slit lamp biomicroscopy, and fundus examination. All eyes included in the study had completely inactive intraocular inflammation for 3 months before surgery. The change in BCVA was the main outcome measure. Results The two groups were age and sex matched. In the ADA group, there was a statistically significant improvement in the mean LogMAR BCVA from 1.063±0.33 preoperatively to 0.538±0.54 postoperatively (P=0.0085), while in the IFX group the mean BCVA improved from 1.183±0.475 preoperatively to 0.683±0.594 postoperatively, with no statistically significant difference (P=0.068). The difference in the postoperative BCVA between the two groups was not statistically significant (P=0.68). A larger percentage of patients in the IFX group developed postoperative inflammation (33.3 vs. 25%). Conclusion The visual acuity improved after cataract extraction in patients with JIA-associated uveitis treated with ADA or IFX, but the improvement was more significant in the patients treated with ADA.https://journals.lww.com/djop/fulltext/2024/25040/outcome_of_cataract_surgery_in_juvenile_idiopathic.3.aspxadalimumab; cataract; infliximab; juvenile idiopathic arthritis; uveitis
spellingShingle Mariam R Fadel
Elzanaty Hassan
T Radwa
Sara M Esmat
Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
Delta Journal of Ophthalmology
adalimumab; cataract; infliximab; juvenile idiopathic arthritis; uveitis
title Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
title_full Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
title_fullStr Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
title_full_unstemmed Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
title_short Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
title_sort outcome of cataract surgery in juvenile idiopathic arthritis associated uveitis under two different biological regimens
topic adalimumab; cataract; infliximab; juvenile idiopathic arthritis; uveitis
url https://journals.lww.com/djop/fulltext/2024/25040/outcome_of_cataract_surgery_in_juvenile_idiopathic.3.aspx
work_keys_str_mv AT mariamrfadel outcomeofcataractsurgeryinjuvenileidiopathicarthritisassociateduveitisundertwodifferentbiologicalregimens
AT elzanatyhassan outcomeofcataractsurgeryinjuvenileidiopathicarthritisassociateduveitisundertwodifferentbiologicalregimens
AT tradwa outcomeofcataractsurgeryinjuvenileidiopathicarthritisassociateduveitisundertwodifferentbiologicalregimens
AT saramesmat outcomeofcataractsurgeryinjuvenileidiopathicarthritisassociateduveitisundertwodifferentbiologicalregimens